Sort
48,018 grants matching “immunotherapy”
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
$501,827Xiongbin Lu · Indiana University Indianapolis · R01 · FY2022 · CA
Local immune modulation for beta cell replacement therapy in type 1 diabetes
$501,826Edward Phelps · University Of Florida · R01 · FY2022 · DK
Virus-Like Particle Based Antigen Display as Multi-component Anticancer Vaccines
$501,816Xuefei Huang · Michigan State University · R01 · FY2011 · CA
CD8+ T Cell Immunity to Cytomegalovirus
$501,799Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2012 · AI
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$501,790Gordon B. Mills · Oregon Health & Science University · U01 · FY2024 · CA
A Novel Device for Determination of GFR Markers
$501,783Bikas Vaidya · Lynntech, Inc. · R44 · FY2007 · DK
Nanoparticles-mediated combination therapy for breast cancer
$501,746Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Focal segmental glomerulosclerosis: Treatment
$501,711Jeffrey Burnett Kopp · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
Evaluation of Immune-based Combinations in Prostate Cancer
$501,693Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$501,670Lingyin Li · Stanford University · R01 · FY2021 · CA
Clinical Investigation of Epigenetic Therapy
$501,619John C Byrd · Ohio State University · P01 · FY2010 · CA
Sunitinib Modulation of Cancer Immunotherapy
$501,600James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · CA
Breast Cancer Treatment with Antibody Targeted T Cells
$501,546Lawrence G Lum · Wayne State University · R01 · FY2010 · CA
Functional Immunomics Core
$501,537Bing Li · University Of Louisville · P20 · FY2022 · GM
Transplant EBV Disease: Pathogenesis and Immunotherapy
$501,505David T Rowe · University Of Pittsburgh At Pittsburgh · P50 · FY2006 · HL
Synaptic Control of Cytotoxic T cell Function
$501,485Morgan A Huse · Sloan-Kettering Inst Can Research · R01 · FY2019 · AI
Understanding mechanisms and consequences of T cell co-receptor regulated RNA maturation
$501,412Scott Henry Olejniczak · Roswell Park Cancer Institute Corp · R01 · FY2025 · AI
Dynamics, Regulation and Function of p53 in Single Cells
$501,357Galit Lahav · Harvard Medical School · R35 · FY2021 · GM
Cytokines driving T cell dysregulation in lacrimal gland autoimmunity
$501,347Scott Matthew Lieberman · University Of Iowa · R01 · FY2020 · EY
Tumor cell metabolism in action
$501,299Eileen White · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response
$501,247Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2022 · CA
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response
$501,247Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2023 · CA
Breast Cancer Treatment with Antibody Targeted T Cells
$501,226Lawrence G Lum · Wayne State University · R01 · FY2009 · CA
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$501,190Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$501,149Marco Ruella · University Of Pennsylvania · R37 · FY2024 · CA